Sky9 Capital

Activity from announced rounds

Activity in this selectionUndisclosed
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$209M
2 disclosed · full round size, not this investor’s share

By stage

Undisclosed2

By primary sector

AI1
Biotech1

By country

China1
United States1

Rounds

2 in this selection
Reactor

Developer platform providing infrastructure for real-time generative video and interactive world models

$59MUndisclosed
Role not disclosed
Full-Life Technologies

Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing

$150MSeries D+Debt
Role not disclosed